Yu Christine, Markan Kathleen, Temple Karla A, Deplewski Dianne, Brady Matthew J, Cohen Ronald N
Section of Endocrinology, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.
J Biol Chem. 2005 Apr 8;280(14):13600-5. doi: 10.1074/jbc.M409468200. Epub 2005 Feb 3.
The peroxisome proliferator-activated receptor gamma (PPARgamma) is a central regulator of adipogenesis and recruits coactivator proteins in response to ligand. However, the role of another class of nuclear cofactors, the nuclear receptor corepressors, in modulating PPARgamma transcriptional activity is less clear. Such corepressors include the nuclear receptor corepressor (NCoR) and the silencing mediator of retinoid and thyroid hormone receptors (SMRT). Our data suggest that PPARgamma recruits SMRT and NCoR in the absence of ligand and that these corepressors are capable of down-regulating PPARgamma-mediated transcriptional activity. The addition of the PPARgamma ligand pioglitazone results in dissociation of the PPARgamma-corepressor complex. To define the role of SMRT and NCoR in PPARgamma action, 3T3-L1 cells deficient in SMRT or NCoR were generated by RNA interference. When these cells are exposed to differentiation media, they exhibit increased expression of adipocyte-specific genes and increased production of lipid droplets, as compared with control cells. These data suggest that the nuclear receptor corepressors decrease PPARgamma transcriptional activity and repress the adipogenic program in 3T3-L1 cells.
过氧化物酶体增殖物激活受体γ(PPARγ)是脂肪生成的核心调节因子,可响应配体募集共激活蛋白。然而,另一类核辅因子,即核受体共抑制因子,在调节PPARγ转录活性中的作用尚不清楚。此类共抑制因子包括核受体共抑制因子(NCoR)和视黄酸及甲状腺激素受体沉默介质(SMRT)。我们的数据表明,PPARγ在无配体时募集SMRT和NCoR,且这些共抑制因子能够下调PPARγ介导的转录活性。添加PPARγ配体吡格列酮会导致PPARγ-共抑制因子复合物解离。为了确定SMRT和NCoR在PPARγ作用中的角色,通过RNA干扰产生了缺乏SMRT或NCoR的3T3-L1细胞。与对照细胞相比,当这些细胞暴露于分化培养基时,它们表现出脂肪细胞特异性基因表达增加以及脂滴生成增加。这些数据表明,核受体共抑制因子降低PPARγ转录活性并抑制3T3-L1细胞中的脂肪生成程序。